期刊文献+

非受体型酪氨酸激酶JAK1基因真核表达质粒的构建与真核表达

Construction of eukaryotic expression vector for nonreceptor tyrosine kinase-JAK1 gene and its expression
原文传递
导出
摘要 [目的]构建非受体型酪氨酸激酶JAK1(nonreceptor tyrosine kinase-JAK1)基因真核表达质粒pcDNA4.0-HisJAK1,并转染293T细胞进行真核表达。[方法]从Hela细胞中提取总的RNA,通过RT-PCR获得JAK1基因全长c DNA序列,并将其克隆至真核表达载体pcDNA4.0-His中,构建重组质粒pcDNA4.0-His-JAK1。将真核重组表达质粒转染293T细胞,转染48 h后,在荧光显微镜下观察转染情况。免疫印迹法检测JAK1蛋白转染24 h、36 h与48 h在293T细胞中的表达。[结果]经双酶切与质粒PCR鉴定质粒克隆正确,测序鉴定序列中第2199位碱基A突变为G,为同义突变,不影响氨基酸序列。转染293T细胞48 h后,间接免疫荧光实验显示在293T细胞中检测到绿色荧光。免疫印迹检测可见大小约为133 kDa的目的蛋白。[结论]成功获得JAK1基因全长序列,并成功构建pcDNA4.0-HisJAK1真核重组表达质粒,并在真核细胞293T中获得有效表达,为进一步研究JAK1蛋白质相互作用奠定了基础。 [ Objective] To construct a eukaryotic expression vector for nonreceptor tyrosine kinase -JAK1 gene and express in 293T cells. [ Methods] Total RNA was extracted from Hela cells ,with which JAK1 gene was amplified by RT - PCR and inserted into eukaryotic expression vector pcDNA4.0 - His. 293T cells were transfected with the constructed recombinant plasmid pcDNA4.0 -His -JAK1, observed by fluorescent microscopy 48 hours later, and determined for expression level of JAK1 by Western Blot 24 hours,36 hours and 48 hours later. [ Results] Restriction analysis and sequencing proved that pcDNA4.0 - His - JAK1 was a correct recombinant plasmid. Green fluorescence was observed in 293T cells 48 h after transfection with the plas- mid. The target protein band by Western Blot. [ Conclusion ] Eukaryotic expression vector pcDNA4.0 - His - JAK1 was successfully constructed and expressed effectively in 293T cells, which laid a foundation of further research on protein -protein interaction of JAK1.
出处 《生物技术》 CAS CSCD 北大核心 2016年第1期18-22,共5页 Biotechnology
基金 国家高技术研究发展计划(863计划)项目("蛋白质相互作用均相发光分析仪器和配套试剂研究" No.2014AA020904)资助
关键词 非受体型酪氨酸激酶 JAK1基因 293T细胞 真核表达 Nonreceptor tyrosine kinase,JAK1 gene,293T cells, eukaryotic expression
  • 相关文献

参考文献17

  • 1Vainchenker W, Dusa A, Constantinescu SN. JAKs in pathology : role of Janus kinases in hematopoietic malignancies and immunode- ficiencies [ J ]. Semin Cell Dev Biol,2008,19 (4) : 385 - 393.
  • 2李丹,李薇,刘念,马克威.JAK1在肿瘤发生和发展中作用的研究进展[J].吉林医学,2009,30(3):279-280. 被引量:6
  • 3宋舟,张立艳,董海兵,白换力,陈伟,吴帅成,伊鹏霏,付本懂,申海清,韦旭斌.JAK-STAT信号通路研究进展[J].中国畜牧兽医,2012,39(6):128-132. 被引量:28
  • 4Wei J,Lian H,Zhong B,et al. Parafibromin is a component of IFN -gamma- triggered signaling pathways that facilitates JAKI/2 - mediated tyrosine phosphorylation of STATI [ J ]. J Immuno1,2015, 195(6) : 2070 -2078.
  • 5Cai B,Cai JP, Luo YL, et al. The specific roles of JAK/STAT sig- naling pathway in sepsis [ J ]. Inflammation, 2015,38 ( 4 ) : 1599 - 1608.
  • 6Lyu JH, Huang B, Park DW, et al. Regulation of PHLDA1 expres- sion by JAK2 - ERK1/2 - STAT3 signaling pathway [ J ]. J Cell Biochem, 2015, doi : 10.1002.
  • 7Sibbesen NA, Kopp KL, Litvinov IV, et al. Jak3, STAT3, and STAT5 inhibit expression of miR - 22, a novel tumor suppressor microRNA, in cutaneous T - cell lymphoma [ J ]. Oncotarget ,2015, 6(24) : 20555 -20569.
  • 8Akahane K, Sanda T, Mansour MR, et al. HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T - cell aeute lymphoblastie leukemia [ J ]. Ikukemia, 2015, Aug 12. doi : 10. 1038.
  • 9王文娟,孙爱宁,陈广华,吴德沛,李渭阳,常伟荣,丁子轩.成人急性T淋巴细胞白血病JAK1基因突变[J].江苏医药,2011,37(8):908-910. 被引量:1
  • 10乔燕燕,贾黾泽,马秀梅,冯璞.JAK1、p-STAT 3和bcl-2在胃癌中的表达及意义[J].肿瘤防治研究,2009,36(8):657-661. 被引量:12

二级参考文献109

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部